JP2011527709A5 - - Google Patents

Download PDF

Info

Publication number
JP2011527709A5
JP2011527709A5 JP2011517670A JP2011517670A JP2011527709A5 JP 2011527709 A5 JP2011527709 A5 JP 2011527709A5 JP 2011517670 A JP2011517670 A JP 2011517670A JP 2011517670 A JP2011517670 A JP 2011517670A JP 2011527709 A5 JP2011527709 A5 JP 2011527709A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
azithromycin
subject
effective amount
blepharitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011517670A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011527709A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/050311 external-priority patent/WO2010006306A1/en
Publication of JP2011527709A publication Critical patent/JP2011527709A/ja
Publication of JP2011527709A5 publication Critical patent/JP2011527709A5/ja
Withdrawn legal-status Critical Current

Links

JP2011517670A 2008-07-10 2009-07-10 眼瞼炎の治療方法 Withdrawn JP2011527709A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7977208P 2008-07-10 2008-07-10
US61/079,772 2008-07-10
PCT/US2009/050311 WO2010006306A1 (en) 2008-07-10 2009-07-10 Method of treating blepharitis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014190105A Division JP2014240433A (ja) 2008-07-10 2014-09-18 眼瞼炎の治療方法

Publications (2)

Publication Number Publication Date
JP2011527709A JP2011527709A (ja) 2011-11-04
JP2011527709A5 true JP2011527709A5 (enExample) 2012-07-12

Family

ID=41507457

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011517670A Withdrawn JP2011527709A (ja) 2008-07-10 2009-07-10 眼瞼炎の治療方法
JP2014190105A Ceased JP2014240433A (ja) 2008-07-10 2014-09-18 眼瞼炎の治療方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014190105A Ceased JP2014240433A (ja) 2008-07-10 2014-09-18 眼瞼炎の治療方法

Country Status (7)

Country Link
US (1) US8349806B2 (enExample)
EP (1) EP2313103B1 (enExample)
JP (2) JP2011527709A (enExample)
AU (1) AU2009268372B2 (enExample)
CA (1) CA2730120A1 (enExample)
MX (1) MX2011000247A (enExample)
WO (1) WO2010006306A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9925087B2 (en) 2000-09-15 2018-03-27 Bruder Healthcare Company, Llc Wound and therapy compress and dressing
US10105259B2 (en) 2000-09-15 2018-10-23 Bruder Healthcare Company, Llc Wound and therapy compress and dressing
ATE460146T1 (de) 2000-09-15 2010-03-15 Bruder Healthcare Co Wund- und behandlungskompresse und verband
US8349806B2 (en) 2008-07-10 2013-01-08 Inspire Pharmaceuticals, Inc. Method of treating blepharitis
US20100190734A1 (en) * 2009-01-23 2010-07-29 Romulus Kimbro Brazzell Method of treating dry eye disease with azithromycin
US20130281390A1 (en) * 2010-12-29 2013-10-24 Kurt E. Brubaker Method for treating dry eye
WO2012092378A1 (en) * 2010-12-29 2012-07-05 Inspire Pharmaceuticals, Inc. Method for treating blepharitis
JP2014518275A (ja) * 2011-06-29 2014-07-28 インサイト・ビジョン・インコーポレイテッド 再発性マイボーム腺障害の処置方法およびそれによる再発頻度の減少方法
WO2013191167A1 (ja) * 2012-06-19 2013-12-27 参天製薬株式会社 ヘアレス動物の眼瞼状態の変化方法
WO2014143139A1 (en) 2013-03-15 2014-09-18 Bruder Healthcare Company Wound and therapy compress and dressing
CN104045674B (zh) * 2014-05-21 2017-01-04 丽珠医药集团股份有限公司 一种阿奇霉素的制备方法
CN105106109A (zh) * 2015-09-11 2015-12-02 江苏锦宇环境工程有限公司 一种阿奇霉素缓释滴眼剂的制备方法
CN108289908A (zh) * 2015-12-22 2018-07-17 日油株式会社 泪液油层稳定剂及含有该泪液油层稳定剂的滴眼剂
US12029681B2 (en) 2016-03-01 2024-07-09 The Hilsinger Company Parent, Llc Therapeutic eye mask system
US12011388B2 (en) 2016-03-01 2024-06-18 The Hilsinger Company Parent, Llc Therapeutic thermal compress with phase-change material
US12156831B2 (en) 2016-03-01 2024-12-03 The Hilsinger Company Parent, Llc Therapeutic eye compress system
US9981041B2 (en) * 2016-08-23 2018-05-29 Ira Jason Salzman Ophthalmic lubricating spray
USD844795S1 (en) 2016-11-30 2019-04-02 Bruder Healthcare Company, Llc Therapeutic eye mask
USD871598S1 (en) 2016-11-30 2019-12-31 Bruder Healthcare Company, Llc Therapeutic eye mask
CN109381707B (zh) * 2017-08-03 2022-02-15 沈阳药科大学 一种阿奇霉素离子对脂质体滴眼液及其制备方法
JP2023133646A (ja) * 2020-06-26 2023-09-27 参天製薬株式会社 脂質分泌促進剤
CA3199736A1 (en) 2020-11-23 2022-05-27 Sight Sciences, Inc. Formulations and methods for treating conditions of the eye
US20240050446A1 (en) * 2021-02-25 2024-02-15 Sun Pharmaceutical Industries Limited Dexamethasone for treatment of blepharitis

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861411B1 (en) 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
ATE319456T1 (de) 1998-05-08 2006-03-15 Univ Miami Verwendung von tetracyclinen zur behandlung von störungen der meibomschen drüsen
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US7063857B1 (en) 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
IT1313610B1 (it) * 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
AR031135A1 (es) 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
WO2004091436A2 (en) 2003-04-15 2004-10-28 The Regents Of The University Of California Methods and compositions for treating ocular disease
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
US20050137205A1 (en) * 2003-12-22 2005-06-23 Van Breen Eduard T. Formulation for treating periocular disease
US8425929B2 (en) 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
WO2005110374A1 (en) 2004-04-30 2005-11-24 Allergan, Inc. Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
US8372814B2 (en) 2004-06-07 2013-02-12 Ista Pharmaceuticals, Inc. Ophthalmic formulations and uses thereof
US8349352B2 (en) 2005-02-04 2013-01-08 Auburn University Therapeutic contact lenses with anti-fungal delivery
US8663639B2 (en) 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
US7247623B2 (en) 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
US20070105788A1 (en) * 2005-11-09 2007-05-10 Serena Mraz-Gernhard Azithromycin for treatment of granulomatous rosacea
TWI435729B (zh) 2005-11-09 2014-05-01 Combinatorx Inc 治療病症之方法,組合物及套組
CA2635797C (en) 2006-02-09 2015-03-31 Macusight, Inc. Stable formulations, and methods of their preparation and use
EP2364707B1 (en) * 2006-08-07 2013-04-03 Bausch & Lomb Incorporated Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof
US11078262B2 (en) 2007-04-30 2021-08-03 Allergan, Inc. High viscosity macromolecular compositions for treating ocular conditions
US20080286338A1 (en) 2007-05-15 2008-11-20 Boston Foundation For Sight Drug delivery system with scleral lens
US8349806B2 (en) 2008-07-10 2013-01-08 Inspire Pharmaceuticals, Inc. Method of treating blepharitis
US20100190734A1 (en) 2009-01-23 2010-07-29 Romulus Kimbro Brazzell Method of treating dry eye disease with azithromycin

Similar Documents

Publication Publication Date Title
JP2011527709A5 (enExample)
MX354456B (es) Silicato de zirconio microporoso para el tratamiento de hipercalemia.
HRP20220902T3 (hr) Pripravci i njihova upotreba u liječenju multiple skleroze
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
JP2014507482A5 (enExample)
HRP20180237T4 (hr) Metode za liječenje hcv-a
EA201200686A1 (ru) Новые терапевтические подходы для лечения болезни альцгеймера
HK1221646A1 (zh) 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途
PH12014500472A1 (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
JP2015025011A5 (enExample)
NO20090068L (no) Aktive agent formuleringer, fremstillingsmetoder, og anvendelsesmetoder
JP2015523546A5 (enExample)
NZ602510A (en) Treatment of lupus nephritis using laquinimod
JP2011509303A5 (enExample)
EA201490163A1 (ru) Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
EA201790406A1 (ru) Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
JP2013231087A5 (enExample)
EA201491606A1 (ru) Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
EA201100921A1 (ru) Соединения, фармацевтические композиции и способы их применения при лечении нарушений обмена веществ
EA201400202A1 (ru) Применение эстетрола в качестве экстренного контрацептива
JP2017002035A5 (enExample)
HRP20190561T1 (hr) Postupci liječenja bolesti oka povezanih s upalom i vaskularnom proliferacijom
EA201490166A1 (ru) Фторированные арилалкиламинокарбоксамидные производные
CA2863829A1 (en) Oral unit dosage forms and uses of same for the treatment of gaucher disease
PH12016500932B1 (en) Method of treating ocular disorders